Cases & Deals

Celgene seeks patent protection for different oral formulations of 5-AZACYTIDINE

Clients Celgene Corporation

Jones Day is prosecuting applications and developing a patent portfolio on behalf of Celgene Corporation for oral formulations of 5-AZACYTIDINE.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.